Impact of non-binding FDA guidances on primary endpoint selection in Alzheimer's disease trials.

Overview
Research
Identity
Additional Document Info
View All

authors

Yu, Jeffrey C
Hlávka, Jakub P
Elizabeth Joe, MD
Richmond, Frances J
Lakdawalla, Darius N

publication date

January 1, 2022

published in

Alzheimer's & dementia (New York, N. Y.) Journal